Baxter International company profile
Company profile
Baxter International has 37,500 employees and is headquartered in Deerfield, United States.
Sterile intravenous solutions, infusion systems and parenteral nutrition therapies are among the products hospitals and patients associate with Baxter. The company also makes surgical hemostat and sealant products, smart bed systems, patient monitoring devices, inhaled anesthetics and generic injectable pharmaceuticals, organized in three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. Its products reach hospitals, nursing homes, dialysis centers, ambulatory surgery centers and patients at home, sold through a direct sales force, independent distributors and drug wholesalers. Markets include the United States, Western Europe, Canada, Japan, Australia, New Zealand, Eastern Europe, Latin America, Asia, the Middle East and Africa.
In the fiscal year ended December 2025, Baxter reported revenue of $11.2 billion, up 5.7% from the previous year, and a net loss of $957 million. The United States accounted for 54.4% of revenue, while Western Europe, Canada, Japan, Australia and New Zealand together accounted for 33.2%. The company had 37,500 employees and is headquartered in Deerfield, Illinois, where it was incorporated in 1931.
Company facts
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Headquarters
- One Baxter Parkway, 60015, Deerfield
- Employees
- 37,500
- Chief executive
- Andrew Hider
- Founded
- 1931
- Fiscal year
- January - December
- Listing
- BAX · NYSE
- Indices
- S&P 500
- Currency
- USD
- ISIN
- US0718131099
- Website
- baxter.com
Baxter International and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| Baxter InternationalBAX | United States | $13.14B | 37,500 | 7.6% | — |
| SolventumSOLV | United States | $14.36B | 20,584 | 5.9% | 94.9 |
| Cooper CompaniesCOO | United States | $11.2B | 15,000 | 12.9% | 20.2 |
| Align TechnologyALGN | United States | $10.94B | 20,180 | 19.6% | 22.6 |
| RepligenRGEN | United States | $10.89B | 2,000 | 8.1% | — |
| AvantorAVTR | United States | $10.06B | 13,500 | 8.0% | 29.7 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
